Last news
California Waste Solutions Leads Youth Education, Worker Programs & Government Delegations As Founder David Duong Says He Will Continue "Reinvesting" In Vietnam

California Waste Solutions Leads Youth Education, Worker Programs & Government Delegations As Founder David Duong Says He Will Continue "Reinvesting" In Vietnam

David Duong supports environmental education for young people in Vietnam while workers at Vietnam Waste Solutions get a free health check-up, in keeping with the company's long-running commitment to its employees' wellbeing. Separately, a delegation...

Getac's Next Generation B360X and B360X Pro Fully Rugged Notebooks Bring the Power of Edge AI to Frontline Professionals

Getac's Next Generation B360X and B360X Pro Fully Rugged Notebooks Bring the Power of Edge AI to Frontline Professionals

Latest additions to Getac's flagship B360 lineup boast advanced Intel® Core™ Ultra Series 3 processors and an expanded 14-inch screen, alongside enhanced security and extensive connectivity options. News in brief: Getac's new B360X and B360X Pro...

Anchanto Partners with JINGDONG Logistics to Help South Korean Brands Sell Across Global Marketplaces

Anchanto Partners with JINGDONG Logistics to Help South Korean Brands Sell Across Global Marketplaces

JINGDONG Logistics will onboard customers through Anchanto's Operations Experience (OXM) platform, connecting online sales channels to logistics operations with more than 200 ready integrations JINGDONG Logistics has partnered with Anchanto to help...

Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep

Carnyx Therapeutics Unveils Oral Sleep Candidate CNYX-005 with Preclinical Data Showing Increased NREM Sleep

Preclinical study shows 1.5- to 2-hour increase in total sleep time as Company advances toward clinical development and attracts Chris Brearley, M.D., as Chief Medical Officer INDIANAPOLIS, Oct. 23, 2026 /PRNewswire/ -- Carnyx Therapeutics Ltd....

Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne

Ascletis' Strategic Partner Sagimet Announces First Patient Dosed in Phase III U.S. Clinical Trial of Denifanstat (ASC40) for Moderate to Severe Acne

- With first patient dosed in Phase III clinical trial, Ascletis' strategic partner Sagimet Biosciences Inc. ("Sagimet") advances denifanstat (ASC40)'s U.S. registrational program, building on positive Phase III clinical results in China from...

Scage Future Announces Effective Date for ADS Ratio Change

Scage Future Announces Effective Date for ADS Ratio Change

NANJING, China, Oct. 23, 2026 /PRNewswire/ -- Scage Future ("Scage Future" or the "Company") (Nasdaq: SCAG), a provider of new energy and zero-emission heavy-duty commercial vehicles and e-fuel solutions, today announced the effective date and new...

Harbour BioMed Receives China NMPA Approval of Batoclimab Injection (Subcutaneous Injection) for the Treatment of Generalized Myasthenia Gravis

Harbour BioMed Receives China NMPA Approval of Batoclimab Injection (Subcutaneous Injection) for the Treatment of Generalized Myasthenia Gravis

The first NMPA-approved anti-FcRn therapy to complete its full clinical development for gMG patients in China CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global...

Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects

Seatrium and Karpowership Sign Contract for a Series of Whale Class Powership Conversion and Integration Projects

SINGAPORE, Oct. 23, 2026 /PRNewswire/ -- Seatrium Limited and its strategic partner, floating power leader Karpowership, have strengthened their longstanding collaboration with the award of a contract for the development, major conversion and...

1 ... 8 9 10 11 12 13 14 15 16 ... 5818
menu
menu